These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16792601

  • 1. Sublingual immunotherapy: from biological extracts to recombinant allergens.
    Moingeon P.
    Allergy; 2006; 61 Suppl 81():15-9. PubMed ID: 16792601
    [Abstract] [Full Text] [Related]

  • 2. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L, Razafindratsita A, St-Lu N, Didierlaurent A, Batard T, Lombardi V, Martin E, Moingeon P.
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.
    O'Hehir RE, Sandrini A, Anderson GP, Rolland JM.
    Curr Med Chem; 2007 Sep; 14(21):2235-44. PubMed ID: 17896972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.
    Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P.
    J Allergy Clin Immunol; 2007 Aug; 120(2):278-85. PubMed ID: 17531296
    [Abstract] [Full Text] [Related]

  • 8. Recombinant allergens for immunotherapy.
    Valenta R, Niederberger V.
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [Abstract] [Full Text] [Related]

  • 9. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA, Barlan IB, Bahceciler N, Akdis M.
    Allergy; 2006 Apr; 61 Suppl 81():11-4. PubMed ID: 16792600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S.
    Lakartidningen; 2006 Apr; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract] [Full Text] [Related]

  • 12. European allergen extract units and potency: review of available information.
    Larenas-Linnemann D, Cox LS, Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):137-45. PubMed ID: 18320915
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of oromucosal immunotherapy in respiratory allergy.
    Brown JL, Frew AJ.
    Clin Exp Allergy; 2001 Jan; 31(1):8-10. PubMed ID: 11167944
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS.
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [Abstract] [Full Text] [Related]

  • 20. Genetic engineering of allergens for immunotherapy.
    Bonura A, Colombo P.
    Inflamm Allergy Drug Targets; 2009 Jun; 8(2):104-9. PubMed ID: 19530992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.